A randomized doubled blinded placebo controlled trial multicentre phase III study of Tarceva plus chemotherapy cisplatin and gemcitabine versus chemotherapy alone in patients with advanced stage IIIB or IV Non Small Cell Lung Cancer NSCLC who have not received prior chemotherapy